Teri Ardleigh Swift

Vice President-Business Development at Tyrogenex, Inc.

Teri Ardleigh Swift

Teri Ardleigh Swift

Vice President-Business Development at Tyrogenex, Inc.

Overview
RelSci Relationships

314

Number of Boards

2

Relationships
RelSci Relationships are individuals Teri Ardleigh Swift likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at The Foundation Fighting Blindness, Inc.

Relationship likelihood: Strong

Co-Founder at Concordia Summit

Relationship likelihood: Strong

Founder at Biotage, Inc.

Relationship likelihood: Strong

Co-Founder at The Foundation Fighting Blindness, Inc.

Relationship likelihood: Strong

Vice Chairman at McLarty Associates

Relationship likelihood: Strong

Former Prime Minister of Spain

Relationship likelihood: Strong

Former Senator from Maine

Relationship likelihood: Strong

Former Governor of New Jersey

Relationship likelihood: Strong

Chief Executive Officer at Puradyn Filter Technologies, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Group of Thirty

Relationship likelihood: Strong

Paths to Teri Ardleigh Swift
Potential Connections via
Relationship Science
You
Teri Ardleigh Swift
Vice President-Business Development at Tyrogenex, Inc.
Career History
Vice President-Business Development
Current

Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD.

Professional
2004 - Prior
Executive Officer
Prior

MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR.

Boards & Committees
Member, Leadership Council
Current

Concordia Summit mission is to identify new avenues of collaboration for governments, businesses, and nonprofits through issue-based campaigns, year round programming, and the Partnership Index. Concordia promotes effective public-private collaboration to create a more prosperous and sustainable future. Concordia has grown towards a belief that P3s are a fundamental tool to addressing many societal challenges. Concordia recognizes that cross-sector collaboration offers a solution.

National Trustee
Current

The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD.

Political Donations
$500
2011

Former Representative from the 92nd District at Illinois House of Representatives

Transactions
Details Hidden

Tyrogenex, Inc. raised money in a private placement transaction

Details Hidden

MolecularMD Corp. raised money in a private placement transaction

Details Hidden

Tyrogenex, Inc. raised money in a private placement transaction